MedPath

A comparative study on the curative effect of acupoint application on patients in remission of allergic asthma which based on the lung-gut axis theory

Phase 1
Conditions
asthma
Registration Number
ITMCTR2100004320
Lead Sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Cases that are clearly diagnosed according to the diagnostic criteria of western medicine for asthma and are in the acute stage of non-asthma;
(2) Remission period of asthma in accordance with TCM syndrome differentiation standards;
(3) Do not use other immune enhancers, do not inhale glucocorticoids or other drugs or short-term inhalation of glucocorticoids (less than 1 month per year) during the treatment;
(4) Aged from 18 to 65 years;
(5) Those who sign an informed consent and are willing to follow the research plan.

Exclusion Criteria

(1) Patients with other diseases that can cause asthma or breathing difficulties;
(2) Pregnant and lactating women who are allergic to the prescription drugs in this trial;
(3) Those who suffer from heart failure, moderate to severe hypertension, diabetes, and other blood system diseases or mental illnesses who cannot cooperate;
(4) People with scar constitution or history of tape allergy, or unhealed wounds exposed in acupoint application;
(5) Other diseases that are not suitable for acupoint application.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical efficacy score;Self-rating anxiety scale;Depression self-rating scale score;Adult asthma quality of life score;
Secondary Outcome Measures
NameTimeMethod
Serum related immune index;
© Copyright 2025. All Rights Reserved by MedPath